Continue to Site

Fresenius Kabi launches sodium chloride injection for maintaining catheter patency

April 21, 2021 By Sean Whooley

Fresenius Kabi Heparin — [Image from Fresenius Kabi]

Fresenius Kabi announced today that it launched two new presentations of Heparin sodium in its Freeflex IV bags.

Lake Zurich, Ill.–based Fresenius Kabi’s Heparin sodium in sodium chloride injection at a concentration of two USP units per ml is indicated as an anticoagulant to maintain catheter patency, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.